Alinity 07P5520Recalls & reported problems
Abbott GmbH · Alinity c Glucose Reagent Kit · Class 2
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380740135447), received between Aug 20, 2019 and Aug 1, 2023 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Low Test Results” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Low Test Results2
- High Test Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 1, 2023Low Test Results; Low Test Results
THE CUSTOMER OBSERVED FALSELY DECREASED GLUCOSE RESULTS GENERATED FROM AN ALINITY C PROCESSING MODULE FOR A FEMALE PATIENT WHO WAS IN THE ICU. THE CUSTOMER PROVIDED THE FOLLOWING DATA: SAMPLE ID (B)(6)WAS ORIGINALLY RUN ON (B)(6)2023 AT 0630 FOR A COMPLETE METABOLIC PANEL. LATER THAT DAY AT APPROXIMATELY 2130 THERE WAS A REQUEST TO ADD A BASIC METABOLIC PANEL. THE RESULTS WERE QUESTIONED ON 20 JULY, SO THE SAMPLE WAS REPEATED ON THE SAME ANALYZER (SN: (B)(6)) AND ALSO REPEATED ON ANOTHER ALINITY C PROCESSING MODULE (SN: (B)(6)) GLUCOSE RESULTS: INITIAL GLUCOSE RESULT ON 18 JULY WAS 53, REPEATED LATER THAT DAY THE RESULT WAS 224, REPEATED ON THE SAME ANALYZER ON 20 JULY WAS 220, REPEATED ON ANOTHER ANALYZER WAS 209. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17437675 ↗MalfunctionJul 22, 2021High Test Results; High Test Results
THE CUSTOMER REPORTED FALSELY ELEVATED GLUCOSE RESULTS ON ONE PATIENT GENERATED ON THE ALINITY C PROCESSING MODULE. THE RESULTS PROVIDED WERE: INITIAL = 13MMOL/L (234.23MG/DL) / RETESTED = 12MMOL/L (216.22MG/DL); THE NEXT DAY, SAME PATIENT, NEW DRAW AT (B)(6) = ABOUT 5 MMOL/L (90.09MG/DL). THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12211544 ↗MalfunctionAug 20, 2019Low Test Results; Low Test Results
THE CUSTOMER REPORTED A FALSELY DECREASED GLUCOSE RESULT GENERATED ON THE ALINITY C ANALYZER ON ONE (B)(6) FEMALE PATIENT. RESULTS PROVIDED: SID (B)(6), (B)(6) 2019 = 28.557 / 367.804 / ANOTHER ALINITY = 365.545 MG/DL. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8910060 ↗
Other HEXOKINASE, GLUCOSE devices
- Glucose HK 4404483190Roche Diagnostics GmbH · HEXOKINASE, GLUCOSE30 reports
- Glucose HK 08057800190Roche Diagnostics GmbH · HEXOKINASE, GLUCOSE19 reports
- ARCHITECT 3L82-21Abbott Laboratories · HEXOKINASE, GLUCOSE14 reports
- Glucose HK Gen3 5168791190Roche Diagnostics GmbH · HEXOKINASE, GLUCOSE10 reports
- ARCHITECT 3L82-22Abbott GmbH · HEXOKINASE, GLUCOSE8 reports
- Glucose HK 4657527190Roche Diagnostics GmbH · HEXOKINASE, GLUCOSE7 reports
- ARCHITECT 3L82-42Abbott GmbH · HEXOKINASE, GLUCOSE4 reports
- Alinity 07P5530Abbott GmbH · HEXOKINASE, GLUCOSE3 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.